இயக்குனர் தகுதி நபர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Kite: New data offers transparency into CAR T cell therapy manufacturing in real world setting
Kite says a two-year retrospective analysis of the commercial manufacturing and supply of its CAR T therapy, called axicabtagene ciloleucel (Yescarta), shows a high manufacturing success rate and a reliable turnaround time.
The data, presented at the virtual 47th European Society for Blood and Marrow Transplantation (EBMT) meeting in March 2021, provides the first real-world insights into axicabtagene ciloleucel (Axi-cel) manufacturing for European, Swiss, and Israeli adult patients with relapsed/refractory diffuse large B cell lymphoma (DLBCL) and primary mediastinal large B cell lymphoma (PMBCL), said the biopharma company. ....

Noord Holland , Los Angeles , Didier Hallard , European Society For Blood , European Medicines Agency , European Society , Marrow Transplantation , Director Qualified Person , நூற்த் ஹாலண்ட் , லாஸ் ஏஞ்சல்ஸ் , ஐரோப்பிய சமூகம் க்கு இரத்தம் , ஐரோப்பிய சமூகம் , மஜ்ஜை மாற்று அறுவை சிகிச்சை , இயக்குனர் தகுதி நபர் ,